A Bio-Inspired Glucose Controller Based on Pancreatic β-Cell Physiology

Introduction: Control algorithms for closed-loop insulin delivery in type 1 diabetes have been mainly based on control engineering or artificial intelligence techniques. These, however, are not based on the physiology of the pancreas but seek to implement engineering solutions to biology. Developments in mathematical models of the β-cell physiology of the pancreas have described the glucose-induced insulin release from pancreatic β cells at a molecular level. This has facilitated development of a new class of bio-inspired glucose control algorithms that replicate the functionality of the biological pancreas. However, technologies for sensing glucose levels and delivering insulin use the subcutaneous route, which is nonphysiological and introduces some challenges. In this article, a novel glucose controller is presented as part of a bio-inspired artificial pancreas. Methods: A mathematical model of β-cell physiology was used as the core of the proposed controller. In order to deal with delays and lack of accuracy introduced by the subcutaneous route, insulin feedback and a gain scheduling strategy were employed. A United States Food and Drug Administration-accepted type 1 diabetes mellitus virtual population was used to validate the presented controller. Results: Premeal and postmeal mean ± standard deviation blood glucose levels for the adult and adolescent populations were well within the target range set for the controller [(70, 180) mg/dl], with a percent time in range of 92.8 ± 7.3% for the adults and 83.5 ± 14% for the adolescents. Conclusions: This article shows for the first time very good glucose control in a virtual population with type 1 diabetes mellitus using a controller based on a subcellular β-cell model.

[1]  Eyal Dassau,et al.  Real-Time Hypoglycemia Prediction Suite Using Continuous Glucose Monitoring , 2010, Diabetes Care.

[2]  Robert G. Sutherlin,et al.  A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes , 2010, Science Translational Medicine.

[3]  Claudio Cobelli,et al.  Cellular modeling: insight into oral minimal models of insulin secretion. , 2010, American journal of physiology. Endocrinology and metabolism.

[4]  E. Atlas,et al.  MD-Logic Artificial Pancreas System , 2010, Diabetes Care.

[5]  E. Atlas,et al.  MD-Logic Artificial Pancreas System: A Pilot Study in Adults with Type 1 Diabetes Mellitus Running Title: Closed-Loop System In Type 1 Diabetes , 2010 .

[6]  C. Toumazou,et al.  A Benchtop Closed-loop System Controlled by a Bio-Inspired Silicon Implementation of the Pancreatic β Cell , 2009, Journal of diabetes science and technology.

[7]  D. B. Keenan,et al.  Delays in Minimally Invasive Continuous Glucose Monitoring Devices: A Review of Current Technology , 2009, Journal of diabetes science and technology.

[8]  Darrell M. Wilson,et al.  A Closed-Loop Artificial Pancreas Using Model Predictive Control and a Sliding Meal Size Estimator , 2009, Journal of diabetes science and technology.

[9]  Boris Kovatchev,et al.  Statistical tools to analyze continuous glucose monitor data. , 2009, Diabetes technology & therapeutics.

[10]  Timothy G. Constandinou,et al.  A neural implant ASIC for the restoration of balance in individuals with vestibular dysfunction , 2009, 2009 IEEE International Symposium on Circuits and Systems.

[11]  Patrick Degenaar,et al.  Optobionic vision—a new genetically enhanced light on retinal prosthesis , 2009, Journal of neural engineering.

[12]  C. Cobelli,et al.  In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes , 2009, Journal of diabetes science and technology.

[13]  Claudio Cobelli,et al.  A subcellular model of glucose-stimulated pancreatic insulin secretion , 2008, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[14]  Lutz Heinemann,et al.  Comparison of the Numerical and Clinical Accuracy of Four Continuous Glucose Monitors , 2008, Diabetes Care.

[15]  Arthur Sherman,et al.  Identifying the targets of the amplifying pathway for insulin secretion in pancreatic beta-cells by kinetic modeling of granule exocytosis. , 2008, Biophysical journal.

[16]  L. Magni,et al.  Evaluating the Efficacy of Closed-Loop Glucose Regulation via Control-Variability Grid Analysis , 2008, Journal of diabetes science and technology.

[17]  F. Doyle,et al.  Detection of a Meal Using Continuous Glucose Monitoring , 2008, Diabetes Care.

[18]  J. Leahy,et al.  Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas , 2008 .

[19]  Alessandro Bertuzzi,et al.  Insulin granule trafficking in beta-cells: mathematical model of glucose-induced insulin secretion. , 2007, American journal of physiology. Endocrinology and metabolism.

[20]  John J Mastrototaro,et al.  Metabolic modelling and the closed-loop insulin delivery problem. , 2006, Diabetes research and clinical practice.

[21]  G. Steil,et al.  Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes , 2006, Diabetes.

[22]  Ricardo Femat,et al.  Fuzzy-Based Controller for Glucose Regulation in Type-1 Diabetic Patients by Subcutaneous Route , 2006, IEEE Transactions on Biomedical Engineering.

[23]  R. Hovorka Continuous glucose monitoring and closed‐loop systems , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[24]  Richard Bertram,et al.  Intra- and inter-islet synchronization of metabolically driven insulin secretion. , 2005, Biophysical journal.

[25]  B. Bequette A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. , 2005, Diabetes technology & therapeutics.

[26]  C. Toumazou,et al.  A 126-/spl mu/W cochlear chip for a totally implantable system , 2005, IEEE Journal of Solid-State Circuits.

[27]  A. Caumo,et al.  First-phase insulin secretion: does it exist in real life? Considerations on shape and function. , 2004, American journal of physiology. Endocrinology and metabolism.

[28]  R. Hovorka,et al.  Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. , 2004, Physiological measurement.

[29]  G. Steil,et al.  Closed-loop insulin delivery-the path to physiological glucose control. , 2004, Advanced drug delivery reviews.

[30]  G. Steil,et al.  Modeling beta-cell insulin secretion--implications for closed-loop glucose homeostasis. , 2003, Diabetes technology & therapeutics.

[31]  Andrea Mari,et al.  Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects. , 2002, American journal of physiology. Endocrinology and metabolism.

[32]  Claudio Cobelli,et al.  Insulin release in impaired glucose tolerance: oral minimal model predicts normal sensitivity to glucose but defective response times. , 2002, Diabetes.

[33]  Lutz Heinemann,et al.  Variability of insulin absorption and insulin action. , 2002, Diabetes technology & therapeutics.

[34]  R. Rowe Insulin pump therapy , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[35]  F Tosi,et al.  Assessment of β‐cell function during the oral glucose tolerance test by a minimal model of insulin secretion , 2001, European journal of clinical investigation.

[36]  C Cobelli,et al.  Quantitative indexes of beta-cell function during graded up&down glucose infusion from C-peptide minimal models. , 2001, American journal of physiology. Endocrinology and metabolism.

[37]  Roman Hovorka,et al.  Pancreatic β-Cell Responsiveness during Meal Tolerance Test: Model Assessment in Normal Subjects and Subjects with Newly Diagnosed Noninsulin-Dependent Diabetes Mellitus1 , 1998 .

[38]  Carver Mead,et al.  Analog VLSI and neural systems , 1989 .

[39]  G. Grodsky,et al.  A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling. , 1972, The Journal of clinical investigation.